PPARA and cancer: However, this study proposes the idea that how/which corepressors keep PPAR signals off in the steady-state condition and how/which coactivators are recruited to drive specific gene transcription upon ligand binding in particular cell types (especially, PPAR target cells in clinical settings such as cancer cells) are also critical.